Cargando…
Radiochemical Feasibility of Mixing of (99m)Tc-MAA and (90)Y-Microspheres with Omnipaque Contrast
Yttrium-90 ((90)Y) microspheres are widely used for the treatment of liver-dominant malignant tumors. They are infused via catheter into the hepatic artery branches supplying the tumor under fluoroscopic guidance based on pre-therapy angiography and Technetium-99m macroaggregated albumin ((99m)Tc-MA...
Autores principales: | Yang, Chang-Tong, Ngam, Pei Ing, Phua, Vanessa Jing Xin, Yu, Sidney Wing Kwong, Apoorva, Gogna, Ng, David Chee Eng, Huang, Hian Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656951/ https://www.ncbi.nlm.nih.gov/pubmed/36364476 http://dx.doi.org/10.3390/molecules27217646 |
Ejemplares similares
-
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015) -
Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022) -
Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023) -
Preclinical Evaluation of (68)Ga-MAA from Commercial Available (99m)Tc-MAA Kit
por: Shanehsazzadeh, Saeed, et al.
Publicado: (2017) -
Utility of Quantitative (99m)Tc-MAA SPECT/CT for (90)yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach
por: Garin, Etienne, et al.
Publicado: (2011)